Oh, what a time to be alive! Just when you thought we had enough on our plate with one virus, along comes Monkeypox to add a little spice to the mix. And guess what? It’s part of the Poxviridae family reunion, featuring double-stranded DNA and not one, but two fabulous genetic clades. Because why settle for one when you can have two?

But fear not, dear reader, for we have a solution straight out of a sci-fi novel: the vaccinia vaccination. It’s like recycling, but for vaccines. Who knew that modifying the smallpox vaccine could be so trendy? And it turns out, it’s quite the party trick against Monkeypox, thanks to their family ties. We’ve got not one, but two FDA-approved vaccines doing the tango against Monkeypox. ACAM2000 is the life of the party until it starts causing cardiac issues, while JYNNEOS is the milder cousin with fewer antics.

But wait, there’s a plot twist! After a 40-year vaccine vacation, Monkeypox decided to come back with a makeover, showing us that viruses too can evolve. Enter the scene: mRNA vaccines, the new kids on the block. These vaccines are like sending a text message to your immune system, telling it to gear up and fight. They’re fast, they’re cheap, and they’re here to save the day against not just one, but many variants.

So, as we stand on the brink of a new era, where mRNA vaccines might just become the new norm against viruses like Monkeypox, let’s take a moment to appreciate the beauty of science. It’s like watching a soap opera, but with viruses and vaccines. And who knows? Maybe mRNA vaccines will become the main character in this ongoing saga. The purpose of this article? To give you a front-row seat to the latest episode in the thrilling adventure of combating Monkeypox. Grab your popcorn, folks; it’s going to be an interesting ride.